JPMorgan upgrades McCormick stock to Overweight on growth prospects

JPMorgan upgraded McCormick & Company (MKC) to Overweight with an $83 price target, citing an attractive entry point after an 11% stock pullback, the company's strong earnings growth track record, and its ability to mitigate tariff impacts. This upgrade follows MKC's Q2 2025 adjusted EPS beat of $0.69 on met revenue expectations of $1.66 billion, driven by robust consumer segment performance. While the company reiterated full-year guidance and some analysts raised price targets, others adjusted theirs down, reflecting varied views on the potential impact of tariffs on MKC's future profitability and global supply chain.

Analysis

McCormick & Company (MKC) has received a significant upgrade to Overweight from Underweight by JPMorgan, with a price target increase to $83 from $69. The upgrade is predicated on a recent 11% share price pullback since early July, which has created what the firm views as an attractive entry point, especially when contrasted with the flat performance of median large-cap food stocks over the same period. This bullish thesis is supported by McCormick's solid second-quarter 2025 results, where it reported an adjusted EPS of $0.69, surpassing the $0.66 analyst consensus, on revenues of $1.66 billion that met expectations. Growth was driven by the Consumer segment, which saw volume and mix increase by over 3%, although this strength was partially offset by softer organic performance in its Flavor Solutions business. Despite acknowledging a persistent premium valuation relative to peers, JPMorgan justifies it with the company's consistent ability to drive positive volume growth and its strong positioning in attractive categories. However, analyst sentiment is not universally positive. While Bernstein also raised its price target to $102, UBS maintained a Neutral rating, and TD Cowen trimmed its target to $82 from $85, specifically citing anticipated costs from tariff impacts. McCormick management has reiterated its full-year 2025 guidance, expressing confidence in its ability to mitigate these tariff-related headwinds through pricing actions.

Key Decisions for Investors

• The 11% stock pullback combined with a Q2 earnings beat and a major analyst upgrade could represent a tactical buying opportunity for investors aligned with JPMorgan's view on the company's justified valuation premium and pricing power.
• Investors should closely monitor the performance of the Flavor Solutions segment in subsequent quarters, as its noted softness presents a key contrast to the robust Consumer division and could signal a targeted area of operational risk.
• The divergent analyst views on tariff impacts highlight a critical uncertainty; therefore, it is prudent to scrutinize management's commentary in future reports for evidence of successful margin protection against these supply chain cost pressures.
• Given that TD Cowen maintains a Buy rating but lowered its price target due to tariffs, investors should consider the near-term margin risk against the firm's projection of 7% earnings growth for fiscal year 2026.